Advertisement

Heat Shock Proteins in Vascular Disease

  • Tapan A. MehtaEmail author
Chapter
Part of the Heat Shock Proteins book series (HESP, volume 5)

Abstract

There is growing evidence that heat shock proteins (HSP), a family of stress-inducible proteins may be involved in the pathogenesis of atherosclerotic vascular diseases. Here we systematically review the evidence behind this notion. A detailed literature search and extensive bibliographic review of literature relating to HSP and atherosclerotic vascular disease. Atherosclerotic vascular disease is classified into four main areas of presentation: carotid, coronary, aortic and peripheral vascular disease, for consideration in this review. In each of these vascular diseases, the evidence linking HSP and atherosclerosis is outlined in a systematic manner. Current evidence suggests that components of the immune system may be involved in the pathogenesis of atherosclerosis, with HSP acting as auto-antigens in the immune response. HSP are detected in atherosclerotic lesions and antibodies to HSP are increased in patients with vascular disease; the rise often correlating with the severity of atherosclerosis. The levels of anti-HSP antibodies have been shown to be independent predictors of risk and have prognostic value. There is a strong link between heat shock protein expression and the principal manifestations of atherosclerotic vascular diseases. A better understanding of this involvement could lead to the development of new and improved treatment strategies

Keywords

HSP atherosclerosis carotid disease coronary disease aortic disease 

Abbreviations

CAD

coronary artery disease

CP

C. Pneumoniae

DM

diabetes mellitus

HSP

heat shock proteins

IRI

ischaemia reperfusion injury

LDL

low-density lipoprotein

References

  1. Ayada, K., Yokota, K., Kobayashi, K., Shoenfeld, Y., Matsuura, E. and Oguma, K. (2007) Chronic infections and atherosclerosis. Ann N Y Acad Sci 1108, 594–602.CrossRefPubMedGoogle Scholar
  2. Beckmann, R. P., Mizzen, L. E. and Welch, W. J. (1990) Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science 248, 850–4.CrossRefPubMedGoogle Scholar
  3. Berberian, P. A., Myers, W., Tytell, M., Challa, V. and Bond, M. G. (1990) Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol 136, 71–80.PubMedGoogle Scholar
  4. Birnie, D. H., Holme, E. R., McKay, I. C., Hood, S., McColl, K. E. and Hillis, W. S. (1998) Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 19, 387–94.CrossRefPubMedGoogle Scholar
  5. Bobryshev, Y. V. and Lord, R. S. (2002) Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J Vasc Surg 35, 368–75.CrossRefPubMedGoogle Scholar
  6. Burian, K., Kis, Z., Virok, D., Endresz, V., Prohaszka, Z., Duba, J., Berencsi, K., Boda, K., Horvath, L., Romics, L., Fust, G. and Gonczol, E. (2001) Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 103, 1503–8.PubMedGoogle Scholar
  7. Chan, Y. C., Shukla, N., Abdus-Samee, M., Berwanger, C. S., Stanford, J., Singh, M., Mansfield, A. O. and Stansby, G. (1999) Anti-heat-shock protein 70 kDa antibodies in vascular patients. Eur J Vasc Endovasc Surg 18, 381–5.CrossRefPubMedGoogle Scholar
  8. Chen, G., Kelly, C., Stokes, K., Wang, J. H., Leahy, A. and Bouchier-Hayes, D. (1997) Induction of heat shock protein 72 kDa expression is associated with attenuation of ischaemia-reperfusion induced microvascular injury. J Surg Res 69, 435–9.CrossRefPubMedGoogle Scholar
  9. Figueredo, A., Ibarra, J. L., Rodriguez, A., Molino, A. M., Gomez-de la Concha, E., Fernandez-Cruz, A. and Patino, R. (1996) Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications. Clin Immunol Immunopathol 79, 252–5.CrossRefPubMedGoogle Scholar
  10. Ford, P. J., Gemmell, E., Chan, A., Carter, C. L., Walker, P. J., Bird, P. S., West, M. J., Cullinan, M. P. and Seymour, G. J. (2006) Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 21, 206–11.CrossRefPubMedGoogle Scholar
  11. Ghayour-Mobarhan, M., Sahebkar, A., Parizadeh, S. M., Moohebati, M., Tavallaie, S., Rezakazemi-Bajestani, S. M., Esmaeili, H. A. and Ferns, G. (2008) Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol 89, 209–15.CrossRefPubMedGoogle Scholar
  12. Giffard, R. G. and Yenari, M. A. (2004) Many mechanisms for hsp70 protection from cerebral ischemia. J Neurosurg Anesthesiol 16, 53–61.CrossRefPubMedGoogle Scholar
  13. Gromadzka, G., Zielinska, J., Ryglewicz, D., Fiszer, U. and Czlonkowska, A. (2001) Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. Cerebrovasc Dis 12, 235–9.CrossRefPubMedGoogle Scholar
  14. Guech-Ongey, M., Brenner, H., Twardella, D. and Rothenbacher, D. (2006) Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study. BMC Cardiovasc Disord 6, 17.CrossRefPubMedGoogle Scholar
  15. Hasan, A., Sadoh, D., Palmer, R., Foo, M., Marber, M. and Lehner, T. (2005) The immune responses to human and microbial heat shock proteins in periodontal disease with and without coronary heart disease. Clin Exp Immunol 142, 585–94.PubMedGoogle Scholar
  16. Heltai, K., Kis, Z., Burian, K., Endresz, V., Veres, A., Ludwig, E., Gonczol, E. and Valyi-Nagy, I. (2004) Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis 173, 339–46.CrossRefPubMedGoogle Scholar
  17. Herz, I., Rosso, R., Roth, A., Keren, G. and George, J. (2006) Serum levels of anti heat shock protein 70 antibodies in patients with stable and unstable angina pectoris. Acute Card Care 8, 46–50.CrossRefPubMedGoogle Scholar
  18. Hoppichler, F., Koch, T., Dzien, A., Gschwandtner, G. and Lechleitner, M. (2000) Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 94, 220–3.CrossRefPubMedGoogle Scholar
  19. Hoppichler, F., Lechleitner, M., Traweger, C., Schett, G., Dzien, A., Sturm, W. and Xu, Q. (1996) Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 126, 333–8.CrossRefPubMedGoogle Scholar
  20. Hoymans, V. Y., Bosmans, J. M., Van Herck, P. L., Ieven, M. M. and Vrints, C. J. (2008) Implications of antibodies to heat-shock proteins in ischemic heart disease. Int J Cardiol 123, 277–82.CrossRefPubMedGoogle Scholar
  21. Huittinen, T., Leinonen, M., Tenkanen, L., Virkkunen, H., Manttari, M., Palosuo, T., Manninen, V. and Saikku, P. (2003) Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 107, 2566–70.CrossRefPubMedGoogle Scholar
  22. Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B. and Chesebro, J. H. (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 15, 1667–87.CrossRefPubMedGoogle Scholar
  23. Ishikawa, K. (2003) Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. Curr Pharm Des 9, 2489–97.CrossRefPubMedGoogle Scholar
  24. Jin, X., Xiao, C., Tanguay, R. M., Yang, L., Wang, F., Chen, M., Fu, X., Wang, R., Deng, J., Deng, Z., Zheng, Y., Wei, Q. and Wu, T. (2004) Correlation of lymphocyte heat shock protein 70 levels with neurologic deficits in elderly patients with cerebral infarction. Am J Med 117, 406–11.CrossRefPubMedGoogle Scholar
  25. Johnson, A. D., Berberian, P. A., Tytell, M. and Bond, M. G. (1993) Atherosclerosis alters the localization of HSP70 in human and macaque aortas. Exp Mol Pathol 58, 155–68.CrossRefPubMedGoogle Scholar
  26. Johnson, A. D., Berberian, P. A., Tytell, M. and Bond, M. G. (1995) Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler Thromb Vasc Biol 15, 27–36.PubMedGoogle Scholar
  27. Kalayoglu, M. V., Indrawati, Morrison, R. P., Morrison, S. G., Yuan, Y. and Byrne, G. I. (2000) Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis 181 Suppl 3, S483–9.CrossRefPubMedGoogle Scholar
  28. Kilgore, J. L., Musch, T. I. and Ross, C. R. (1998) Physical activity, muscle, and the HSP70 response. Can J Appl Physiol 23, 245–60.PubMedGoogle Scholar
  29. Kirby, L. B., Mondy, J. S. and Brophy, C. M. (1999) Balloon angioplasty induces heat shock protein 70 in human blood vessels. Ann Vasc Surg 13, 475–9.CrossRefPubMedGoogle Scholar
  30. Kleindienst, R., Xu, Q., Willeit, J., Waldenberger, F. R., Weimann, S. and Wick, G. (1993) Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 142, 1927–37.PubMedGoogle Scholar
  31. Knoflach, M., Kiechl, S., Kind, M., Said, M., Sief, R., Gisinger, M., van der Zee, R., Gaston, H., Jarosch, E., Willeit, J. and Wick, G. (2003) Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 108, 1064–9.CrossRefPubMedGoogle Scholar
  32. Knoflach, M., Kiechl, S., Mayrl, B., Kind, M., Gaston, J. S., van der Zee, R., Faggionato, A., Mayr, A., Willeit, J. and Wick, G. (2007) T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 195, 333–8.CrossRefPubMedGoogle Scholar
  33. Kol, A., Sukhova, G. K., Lichtman, A. H. and Libby, P. (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98, 300–7.PubMedGoogle Scholar
  34. Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. and Grayston, J. T. (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841–9.PubMedGoogle Scholar
  35. Kuroda, S., Kobayashi, T., Ishii, N., Ikeda, J., Shinohe, Y., Houkin, K., Iwasaki, Y. and Nagashima, K. (2003) Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery. Neuropathology 23, 1–8.CrossRefPubMedGoogle Scholar
  36. Leinonen, M. and Saikku, P. (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2, 11–7.CrossRefPubMedGoogle Scholar
  37. Leng, G. C., Lee, A. J., Fowkes, F. G., Whiteman, M., Dunbar, J., Housley, E. and Ruckley, C. V. (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25, 1172–81.CrossRefPubMedGoogle Scholar
  38. Lenzi, C., Palazzuoli, A., Giordano, N., Alegente, G., Gonnelli, C., Campagna, M. S., Santucci, A., Sozzi, M., Papakostas, P., Rollo, F., Nuti, R. and Figura, N. (2006) H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol 12, 7815–20.PubMedGoogle Scholar
  39. Lewthwaite, J., Owen, N., Coates, A., Henderson, B. and Steptoe, A. (2002) Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 106, 196–201.CrossRefPubMedGoogle Scholar
  40. Lindquist, S. (1986) The heat-shock response. Annu Rev Biochem 55, 1151–91.CrossRefPubMedGoogle Scholar
  41. Liu, Y., Lehmann, M., Baur, C., Storck, M., Sunder-Plassmann, L. and Steinacker, J. M. (2002) HSP70 expression in skeletal muscle of patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 24, 269–73.CrossRefPubMedGoogle Scholar
  42. Mahdi, O. S., Horne, B. D., Mullen, K., Muhlestein, J. B. and Byrne, G. I. (2002) Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 106, 1659–63.CrossRefPubMedGoogle Scholar
  43. Mandal, K., Foteinos, G., Jahangiri, M. and Xu, Q. (2005) Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 14, 742–6.CrossRefPubMedGoogle Scholar
  44. Mandal, K., Jahangiri, M. and Xu, Q. (2004) Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 3, 31–7.CrossRefPubMedGoogle Scholar
  45. Martin-Ventura, J. L., Leclercq, A., Blanco-Colio, L. M., Egido, J., Rossignol, P., Meilhac, O. and Michel, J. B. (2007) Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 194, 334–41.CrossRefPubMedGoogle Scholar
  46. Mayr, M., Kiechl, S., Willeit, J., Wick, G. and Xu, Q. (2000) Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102, 833–9.PubMedGoogle Scholar
  47. Meijer, A., van Der Vliet, J. A., Roholl, P. J., Gielis-Proper, S. K., de Vries, A. and Ossewaarde, J. M. (1999) Chlamydia pneumoniae in abdominal aortic aneurysms: abundance of membrane components in the absence of heat shock protein 60 and DNA. Arterioscler Thromb Vasc Biol 19, 2680–6.PubMedGoogle Scholar
  48. Mosorin, M., Surcel, H. M., Laurila, A., Lehtinen, M., Karttunen, R., Juvonen, J., Paavonen, J., Morrison, R. P., Saikku, P. and Juvonen, T. (2000) Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 20, 1061–7.PubMedGoogle Scholar
  49. Muhlestein, J. B. (2002) Secondary prevention of coronary artery disease with antimicrobials: current status and future directions. Am J Cardiovasc Drugs 2, 107–18.CrossRefPubMedGoogle Scholar
  50. Mukherjee, M., De Benedictis, C., Jewitt, D. and Kakkar, V. V. (1996) Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis. Thromb Haemost 75, 258–60.PubMedGoogle Scholar
  51. Park, H. K., Park, E. C., Bae, S. W., Park, M. Y., Kim, S. W., Yoo, H. S., Tudev, M., Ko, Y. H., Choi, Y. H., Kim, S., Kim, D. I., Kim, Y. W., Lee, B. B., Yoon, J. B. and Park, J. E. (2006) Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 114, 886–93.CrossRefPubMedGoogle Scholar
  52. Pockley, A. (2003) Heat shock proteins as regulators of the immune response. Lancet 362, 469–76.CrossRefPubMedGoogle Scholar
  53. Pockley, A. G., Bulmer, J., Hanks, B. M. and Wright, B. H. (1999) Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4, 29–35.CrossRefPubMedGoogle Scholar
  54. Pockley, A. G., De Faire, U., Kiessling, R., Lemne, C., Thulin, T. and Frostegard, J. (2002) Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 20, 1815–20.CrossRefPubMedGoogle Scholar
  55. Pockley, A. G., Georgiades, A., Thulin, T., de Faire, U. and Frostegard, J. (2003) Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42, 235–8.CrossRefPubMedGoogle Scholar
  56. Pockley, A. G., Shepherd, J. and Corton, J. M. (1998) Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest 27, 367–77.CrossRefPubMedGoogle Scholar
  57. Ramirez, J. A. (1996) Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125, 979–82.PubMedGoogle Scholar
  58. Rigano, R., Profumo, E., Buttari, B., Tagliani, A., Petrone, L., D’Amati, G., Ippoliti, F., Capoano, R., Fumagalli, L., Salvati, B. and Businaro, R. (2007) Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann N Y Acad Sci 1107, 1–10.CrossRefPubMedGoogle Scholar
  59. Ritossa, F. (1962) A new puffing pattern induced and temperature shock and DNP in Drosophilia. Experimentia 18, 571–3.CrossRefGoogle Scholar
  60. Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Makela, P. H., Huttunen, J. K. and Valtonen, V. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983–6.CrossRefPubMedGoogle Scholar
  61. Saikku, P., Leinonen, M., Tenkanen, L., Linnanmaki, E., Ekman, M. R., Manninen, V., Manttari, M., Frick, M. H. and Huttunen, J. K. (1992) Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116, 273–8.PubMedGoogle Scholar
  62. Satoh, M., Shimoda, Y., Akatsu, T., Ishikawa, Y., Minami, Y. and Nakamura, M. (2006) Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 8, 810–5.CrossRefPubMedGoogle Scholar
  63. Shamaei-Tousi, A., Stephens, J. W., Bin, R., Cooper, J. A., Steptoe, A., Coates, A. R., Henderson, B. and Humphries, S. E. (2006) Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 27, 1565–70.CrossRefPubMedGoogle Scholar
  64. Shin, Y. O., Bae, J. S., Lee, J. B., Kim, J. K., Kim, Y. J., Kim, C., Ahn, J. K., Bang, I. K., Lee, B. K., Othman, T., Min, Y. K. and Yang, H. M. (2006) Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention. Int Heart J 47, 671–82.CrossRefPubMedGoogle Scholar
  65. Tallot, P., Grongnet, J. F. and David, J. C. (2003) Dual perinatal and developmental expression of the small heat shock proteins [FC12]aB-crystallin and Hsp27 in different tissues of the developing piglet. Biol Neonate 83, 281–8.CrossRefPubMedGoogle Scholar
  66. Tisi, P. V. and Shearman, C. P. (1998) The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking? Eur J Vasc Endovasc Surg 15, 7–17.CrossRefPubMedGoogle Scholar
  67. Tsirpanlis, G. (2004) Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients? Kidney Blood Press Res 27, 134–42.CrossRefPubMedGoogle Scholar
  68. Vander Heide, R. S. (2002) Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 282, H935–41.PubMedGoogle Scholar
  69. Walsh, R. C., Koukoulas, I., Garnham, A., Moseley, P. L., Hargreaves, M. and Febbraio, M. A. (2001) Exercise increases serum Hsp72 in humans. Cell Stress Chaperones 6, 386–93.CrossRefPubMedGoogle Scholar
  70. Whitley, D., Goldberg, S. P. and Jordan, W. D. (1999) Heat shock proteins: a review of the molecular chaperones. J Vasc Surg 29, 748–51.CrossRefPubMedGoogle Scholar
  71. Wick, G. (2006) The heat is on: heat-shock proteins and atherosclerosis. Circulation 114, 870–2.CrossRefPubMedGoogle Scholar
  72. Wick, G., Knoflach, M. and Xu, Q. (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22, 361–403.CrossRefPubMedGoogle Scholar
  73. Wick, G., Perschinka, H. and Millonig, G. (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol 22, 665–9.CrossRefPubMedGoogle Scholar
  74. Wright, B. H., Corton, J. M., El-Nahas, A. M., Wood, R. F. and Pockley, A. G. (2000) Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels 15, 18–22.CrossRefPubMedGoogle Scholar
  75. Xiao, Q., Mandal, K., Schett, G., Mayr, M., Wick, G., Oberhollenzer, F., Willeit, J., Kiechl, S. and Xu, Q. (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 36, 2571–6.CrossRefPubMedGoogle Scholar
  76. Xu, Q., Kiechl, S., Mayr, M., Metzler, B., Egger, G., Oberhollenzer, F., Willeit, J. and Wick, G. (1999) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100, 1169–74.PubMedGoogle Scholar
  77. Xu, Q., Schett, G., Perschinka, H., Mayr, M., Egger, G., Oberhollenzer, F., Willeit, J., Kiechl, S. and Wick, G. (2000) Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102, 14–20.PubMedGoogle Scholar
  78. Xu, Q., Willeit, J., Marosi, M., Kleindienst, R., Oberhollenzer, F., Kiechl, S., Stulnig, T., Luef, G. and Wick, G. (1993) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341, 255–9.CrossRefPubMedGoogle Scholar
  79. Zhang, X., He, M. A., Cheng, L., Zhou, L., Zeng, H., Wang, J., Wang, F., Chen, Y., Hu, F. B. and Wu, T. (2008) Joint effects of antibody to heat shock protein 60, hypertension, and diabetes on risk of coronary heart disease in Chinese. Clin Chem 54, 1046–52.CrossRefPubMedGoogle Scholar
  80. Zhou, X. and Hansson, G. K. (2004) Immunomodulation and vaccination for atherosclerosis. Expert Opin Biol Ther 4, 599–612.CrossRefPubMedGoogle Scholar
  81. Zhu, J., Quyyumi, A. A., Rott, D., Csako, G., Wu, H., Halcox, J. and Epstein, S. E. (2001) Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 103, 1071–5.PubMedGoogle Scholar
  82. Zhu, J., Quyyumi, A. A., Wu, H., Csako, G., Rott, D., Zalles-Ganley, A., Ogunmakinwa, J., Halcox, J. and Epstein, S. E. (2003) Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 23, 1055–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Academic Surgical UnitUniversity Of HullHullUK
  2. 2.Vascular Laboratory, Hull Royal InfirmaryHullUK

Personalised recommendations